You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

ORUVAIL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Oruvail, and what generic alternatives are available?

Oruvail is a drug marketed by Wyeth Pharms Inc and is included in one NDA.

The generic ingredient in ORUVAIL is ketoprofen. There are twenty-seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the ketoprofen profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Oruvail

A generic version of ORUVAIL was approved as ketoprofen by TEVA on December 22nd, 1992.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ORUVAIL?
  • What are the global sales for ORUVAIL?
  • What is Average Wholesale Price for ORUVAIL?
Summary for ORUVAIL
Drug patent expirations by year for ORUVAIL
Recent Clinical Trials for ORUVAIL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Mae Stone Goode FoundationPhase 2/Phase 3
University of RochesterPhase 2/Phase 3
Sanford ResearchEarly Phase 1

See all ORUVAIL clinical trials

US Patents and Regulatory Information for ORUVAIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Pharms Inc ORUVAIL ketoprofen CAPSULE, EXTENDED RELEASE;ORAL 019816-003 Feb 8, 1995 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Wyeth Pharms Inc ORUVAIL ketoprofen CAPSULE, EXTENDED RELEASE;ORAL 019816-002 Feb 8, 1995 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Wyeth Pharms Inc ORUVAIL ketoprofen CAPSULE, EXTENDED RELEASE;ORAL 019816-001 Sep 24, 1993 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.